Phase 4 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 20 and 80 years old.
- People rated as ASA physical status class I, II, or III, meaning their overall health falls within a range accepted by the trial (confirm with trial site).
- People who are having part of their liver surgically removed to treat liver cancer (hepatocellular carcinoma) under general anaesthesia.
Who may not be able to join:
- People who have a severe mental health condition.
- Women who are pregnant or currently breastfeeding.
- People who are classified as morbidly obese.
- People who have a known allergy to any of the medications used in this study.
- People whose liver cancer has come back, or who have had previous surgery for this condition.
- People whose procedure is for a biopsy only.
- Cases where the required information could not be fully collected before surgery.
- People who are expected to receive palliative (comfort-focused) care after surgery rather than curative treatment.
- People being treated for another type of cancer at the same time.
- People whose anaesthesia involves a combination of propofol and inhaled anaesthetic agents, or who receive other specific anaesthetic drugs such as ketamine or dexmedetomidine.
- People whose liver tumour has been diagnosed as non-cancerous (benign).
- People requiring emergency surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 07-3121101
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival; The presence of disease progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.